(Q37976890)

26 August 2017

title

Liver X receptors bridge hepatic lipid metabolism and inflammation (English)

1 reference

26 August 2017

Yuan Liu

1

1 reference

26 August 2017

De Kai Qiu

series ordinal

2

1 reference

26 August 2017

Xiong Ma

series ordinal

3

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Journal of Digestive Diseases

26 August 2017

published in

1 reference

26 August 2017

volume

13

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

69-74

1 reference

LXR, a nuclear receptor that defines a distinct retinoid response pathway

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

The role of orphan nuclear receptors in the regulation of cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

A transcriptional co-repressor that interacts with nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

T0901317 is a dual LXR/FXR agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

The nuclear receptor LXR is a glucose sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X receptors as integrators of metabolic and inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

LXRalpha regulates human CETP expression in vitro and in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

SREBP transcription factors: master regulators of lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Accumulation of foam cells in liver X receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Induction of SREBP-1c mRNA by differentiation and LXR ligand in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Pathology of fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Nonalcoholic fatty liver disease: pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

Liver X Receptor Activation Potentiates the Lipopolysaccharide Response in Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00554.X

10.1111/J.1751-2980.2011.00554.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference